Literature DB >> 8798630

Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase.

H M Muller-Steffner1, A Augustin, F Schuber.   

Abstract

We have shown that bovine spleen NAD+ glycohydrolase (EC), purified to homogeneity, is a multifunctional enzyme. A time-dependent formation of cADPR from NAD+ that did not exceed 1.5-2% of the reaction products was measurable. The cyclase activity of this enzyme was, however, best evidenced by its transformation of NGD+ into cyclic GDP-ribose (cGDPR). The formation of the cyclic compound could be monitored spectroscopically (UV and fluorescence) and by high-performance liquid chromatography; the product ratio of cGDPR/GDP-ribose was 2:1. Bovine spleen NAD+ glycohydrolase is also able to hydrolyze cADPR (Muller-Steffner et al. (1994) Biochem. Biophys. Res. Commun. 204, 1279-1285); the kinetic parameters (V/Km) measured exclude, however, the possibility that cADPR is a kinetically competent reaction intermediate in the transformation of NAD+ into ADP-ribose. Experimental data indicating that NAD+ glycohydrolase-catalyzed hydrolysis and methanolysis of NA(G)D+ occurred at the expense of the formation of the cyclic compounds are in favor of a reaction mechanism involving the partitioning of a common oxocarbenium reaction intermediate between the different acceptors. Thus E.A(G)DP-ribosyl oxocarbenium intermediate can react according to i) intramolecular processes with the positions N-1 of adenine and N-7 of guanine to give cA(G)DPR as reaction products, and ii) intermolecular reactions with water (formation of A(G)DP-ribose) and methanol (formation of methyl A(G)DP-ribose). We attribute the marked difference in yield of cADPR and cGDPR to the intrinsic reactivity (nucleophilicity and positioning) of the purine N-positions that are involved in the cyclization reactions within the E.A(G)DP-ribosyl oxocarbenium complexes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798630     DOI: 10.1074/jbc.271.39.23967

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage.

Authors:  Brian C Smith; John M Denu
Journal:  J Am Chem Soc       Date:  2007-04-17       Impact factor: 15.419

3.  Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.

Authors:  Takayuki Ikeda; Shin Takasawa; Naoya Noguchi; Koji Nata; Akiyo Yamauchi; Iwao Takahashi; Takeo Yoshikawa; Akira Sugawara; Hideto Yonekura; Hiroshi Okamoto
Journal:  Mol Cell Biochem       Date:  2012-03-16       Impact factor: 3.396

Review 4.  Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.

Authors:  H C Lee; C Munshi; R Graeff
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

5.  Human CD38 is an authentic NAD(P)+ glycohydrolase.

Authors:  V Berthelier; J M Tixier; H Muller-Steffner; F Schuber; P Deterre
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

6.  Redesign of Schistosoma mansoni NAD+ catabolizing enzyme: active site H103W mutation restores ADP-ribosyl cyclase activity.

Authors:  Isabelle Kuhn; Esther Kellenberger; Didier Rognan; Frances E Lund; Hélène Muller-Steffner; Francis Schuber
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

7.  Sir2 protein deacetylases: evidence for chemical intermediates and functions of a conserved histidine.

Authors:  Brian C Smith; John M Denu
Journal:  Biochemistry       Date:  2006-01-10       Impact factor: 3.162

8.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  DNA-N-glycosylases process novel O-glycosidic sites in DNA.

Authors:  Suzanne J Admiraal; Patrick J O'Brien
Journal:  Biochemistry       Date:  2013-05-30       Impact factor: 3.162

10.  Covalent and noncovalent intermediates of an NAD utilizing enzyme, human CD38.

Authors:  Qun Liu; Irina A Kriksunov; Hong Jiang; Richard Graeff; Hening Lin; Hon Cheung Lee; Quan Hao
Journal:  Chem Biol       Date:  2008-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.